The 24-Hour Effects of Glyburide Chlorpropamide After Chronic Treatment of Type II Diabetic Patients
- 1 May 1985
- journal article
- clinical trial
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 289 (5) , 179-185
- https://doi.org/10.1097/00000441-198505000-00001
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- The “Dawn Phenomenon” — A Common Occurrence in Both Non-Insulin-Dependent and Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1984
- Non-insulin-dependent diabetes mellitus: Interplay between B-cell inadequacy and insulin resistanceThe American Journal of Medicine, 1982
- Factors Moderating the Effect of Oral Sulfonylureas on Free Water ClearanceThe Journal of Clinical Pharmacology, 1982
- The Dawn Phenomenon, an Early Morning Glucose Rise: Implications for Diabetic Intraday Blood Glucose VariationDiabetes Care, 1981
- Comparative Single‐Dose Kinetics and Effects of Four Sulfonylureas in Healthy VolunteersActa Medica Scandinavica, 1980
- Chlorpropamide-alcohol flushing: a definition of its relation to non-insulin-dependent diabetes.BMJ, 1978
- Abnormal alpha cell function in human diabetesThe American Journal of Medicine, 1978
- Displacement of tolbutamide, glibenclamide and chlorpropamide from serum albumin by anionic drugsBiochemical Pharmacology, 1976
- Diurnal Variation in Oral Glucose Tolerance: Blood Sugar and Plasma Insulin Levels Morning, Afternoon, and EveningBMJ, 1972
- BLOOD LIPID AND GLUCOSE LEVELS OF PATIENTS WITH DIABETES MELLITUS TREATED WITH CHLORPROPAMIDEThe Lancet Healthy Longevity, 1964